GW PHARMACEUTICALS PLC Share-based Payment Arrangement, Expense
GW PHARMACEUTICALS PLC reported Share-based Payment Arrangement, Expense of $16.83 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-03.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2021-05-03
- GW PHARMACEUTICALS PLC share-based payment arrangement, expense for the quarter ending 2021-03-31 was $16.83M, a 59.40% increase year-over-year.
- GW PHARMACEUTICALS PLC share-based payment arrangement, expense for the quarter ending 2020-12-31 was $17.03M, a 45.40% increase year-over-year.
- GW PHARMACEUTICALS PLC share-based payment arrangement, expense for the quarter ending 2020-09-30 was $14.86M, a 29.39% increase year-over-year.
- GW PHARMACEUTICALS PLC share-based payment arrangement, expense for the quarter ending 2020-06-30 was $12.53M, a 8.83% increase year-over-year.
- GW PHARMACEUTICALS PLC share-based payment arrangement, expense for fiscal 2020 was $54.98M, a 21.58% increase from fiscal 2019.
- GW PHARMACEUTICALS PLC share-based payment arrangement, expense for fiscal 2019 was $45.23M.
- GW PHARMACEUTICALS PLC share-based payment arrangement, expense for fiscal 2018 was $31.63M, a 104.32% increase from fiscal 2017.
- GW PHARMACEUTICALS PLC share-based payment arrangement, expense for fiscal 2017 was $15.48M, a 22.26% increase from fiscal 2016.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2021-03-31 | $16.83M 10-Q · filed 2021-05-03 | $33.86M derived: sum of 2 quarters · filed 2021-05-03 | $48.72M derived: sum of 3 quarters · filed 2021-05-03 | $61.25M derived: sum of 4 quarters · filed 2021-05-03 |
| 2020-12-31 | $17.03M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $31.89M derived: sum of 2 quarters · filed 2021-02-26 | $44.42M derived: sum of 3 quarters · filed 2021-02-26 | $54.98M 10-K · filed 2021-02-26 |
| 2020-09-30 | $14.86M 10-Q · filed 2020-11-05 | $27.39M derived: sum of 2 quarters · filed 2020-11-05 | $37.95M 10-Q · filed 2020-11-05 | $49.66M derived: sum of 4 quarters · filed 2021-05-03 |
| 2020-06-30 | $12.53M 10-Q · filed 2020-08-07 | $23.09M 10-Q · filed 2020-08-07 | $34.80M derived: sum of 3 quarters · filed 2021-05-03 | $46.29M derived: sum of 4 quarters · filed 2021-05-03 |
| 2020-03-31 | $10.56M 10-Q · filed 2021-05-03 | $22.27M derived: sum of 2 quarters · filed 2021-05-03 | $33.76M derived: sum of 3 quarters · filed 2021-05-03 | $45.27M derived: sum of 4 quarters · filed 2021-05-03 |
| 2019-12-31 | $11.71M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $23.20M derived: sum of 2 quarters · filed 2021-02-26 | $34.71M derived: sum of 3 quarters · filed 2021-02-26 | $45.23M 10-K · filed 2021-02-26 |
| 2019-09-30 | $11.48M 10-Q · filed 2020-11-05 | $23.00M derived: sum of 2 quarters · filed 2020-11-05 | $33.51M 10-Q · filed 2020-11-05 | $42.78M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $11.52M 10-Q · filed 2020-08-07 | $22.03M 10-Q · filed 2020-08-07 | $31.30M derived: sum of 3 quarters · filed 2021-02-26 | $40.37M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $10.51M 10-Q · filed 2020-05-11 | $19.78M derived: sum of 2 quarters · filed 2021-02-26 | $28.85M derived: sum of 3 quarters · filed 2021-02-26 | $37.87M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $9.27M 10-K · filed 2021-02-26 | $18.34M derived: sum of 2 quarters · filed 2021-02-26 | $27.36M derived: sum of 3 quarters · filed 2021-02-26 | $33.80M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-09-30 | $9.07M 10-Q · filed 2019-11-06 | $18.09M derived: sum of 2 quarters · filed 2019-11-06 | $24.54M 10-Q · filed 2019-11-06 | $31.63M 10-K · filed 2021-02-26 |
| 2018-06-30 | $9.02M 10-Q · filed 2019-08-07 | $15.47M 10-Q · filed 2019-08-07 | ||
| 2018-03-31 | $6.45M 10-Q · filed 2019-05-08 | |||
| 2017-09-30 | $15.48M 10-K · filed 2020-02-27 | |||
| 2016-09-30 | $12.66M 10-KT · filed 2019-02-28 |